NEW YORK (GenomeWeb) – Sophia Genetics, a developer of bioinformatics for analyzing genetic test data, today said that it has raised $13.75 million in a Series B financing round.

The Lausanne, Switzerland-based company offers a software as a service called dropGen, which provides bioinformatic analyis, the validation and quality control process, and the presentation of genetic test results to clinicians while protecting patient DNA sequence data through safe storage and banking, it said.

The financing round was led by Invoke Capital, Swisscom, and Endeavour Vision.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.